{"profile":{"id":"06cb6e28-7aca-4df3-b124-3185c72a2a1f","slug":"chrysalis-biotherapeutics-inc-galveston-9f30","business_name":"Chrysalis Biotherapeutics, Inc.","website_url":"https://chrysbio.com","industry":"Pharmaceutical company","city":"Galveston","services":[{"category":"product","price_range":null,"service_area":null,"service_name":"TP508 Peptide Technology","target_customer":"Patients with acute respiratory distress syndrome or radiation exposure","factual_description":"An injectable drug designed to mitigate vascular damage, hemorrhage, and inflammation, and activate stem cells for tissue regeneration.","related_capabilities":[]},{"category":"service","price_range":null,"service_area":null,"service_name":"Treatments for Acute Respiratory Distress Syndrome (ARDS)","target_customer":"Patients suffering from severe respiratory disorders","factual_description":"Development and commercialization of therapies for ARDS, including those caused by viral infections like COVID-19.","related_capabilities":[]},{"category":"service","price_range":null,"service_area":null,"service_name":"Solutions for Acute Radiation Exposure","target_customer":"Individuals exposed to high levels of nuclear radiation","factual_description":"Development of medical countermeasures to mitigate the effects of radiation exposure and increase survival rates.","related_capabilities":[]}],"schema_json":{"@graph":[{"@id":"https://www.vizoryo.com/en/business/pharmaceutical-company/galveston/chrysalis-biotherapeutics-inc#business","geo":{"@type":"GeoCoordinates","latitude":29.3059916,"longitude":-94.793437},"url":"https://chrysbio.com","name":"Chrysalis Biotherapeutics, Inc.","@type":"LocalBusiness","image":"https://chrysbio.com/wp-content/uploads/2023/09/shutterstock_1505876450.jpg","hasMap":"https://www.google.com/maps/place/?cid=10723983205640900142","sameAs":["https://www.facebook.com/Chrysalis-Bio-Therapeutics-201562923330088/","https://twitter.com/chrysbioTX","https://www.google.com/maps/place/?cid=10723983205640900142"],"address":{"@type":"PostalAddress","postalCode":"77550","addressRegion":"Texas","streetAddress":"2200 Market St, Galveston, TX 77550","addressCountry":"US","addressLocality":"Galveston"},"audience":[{"@type":"Audience","audienceType":"Patients with serious respiratory disorders"},{"@type":"Audience","audienceType":"Individuals at risk of acute radiation exposure"},{"@type":"Audience","audienceType":"Medical professionals and researchers"}],"speakable":{"@type":"SpeakableSpecification","cssSelector":["[data-ai-block=\"summary\"]","[data-ai-block=\"about\"]","[data-ai-block=\"micro-faq\"]","[data-ai-block=\"faq\"]"]},"telephone":"+14094974083","areaServed":[{"name":"Galveston","@type":"City"}],"identifier":[{"@type":"PropertyValue","value":"ChIJccSGq2ueP4YRLg57Teg905Q","propertyID":"Google Place ID"},{"@type":"PropertyValue","propertyID":"VizoryoProfileID","value":"vizoryo:profile:06cb6e28-7aca-4df3-b124-3185c72a2a1f"}],"knowsAbout":["Clinical stage biotechnology"],"description":"A pharmaceutical company in Galveston, United States, Chrysalis Biotherapeutics, Inc. focuses on clinical stage biotechnology. The company develops TP508 Peptide Technology and treatments for conditions such as Acute Respiratory Distress Syndrome (ARDS). It also provides solutions for acute radiation exposure, serving patients with serious respiratory disorders and individuals at risk of radiation exposure.","dateModified":"2026-06-12","datePublished":"2026-06-12","additionalType":"Pharmaceutical Company","mainEntityOfPage":"https://www.vizoryo.com/en/business/pharmaceutical-company/galveston/chrysalis-biotherapeutics-inc","additionalProperty":[{"@type":"PropertyValue","name":"dataConfidence","description":"Cross-source data consistency score (0–1). Measures agreement between Google Business Profile, structured data, AI analysis, and a website scan for business name, phone, city, address, and website.","value":0.9},{"@type":"PropertyValue","name":"sourcesCrossChecked","description":"Count of public sources this record was read from and compared across for the core business details (name, phone, address, city, category, website). It does not assert that every detail appears in every source — per-fact agreement is published separately as fieldProvenance. The sources are not necessarily independent of one another. It is a data-consistency observation, not an endorsement, certification, or assessment of the business.","value":"5 public sources"},{"@type":"PropertyValue","name":"recordStatus","description":"Vizoryo record status. owner_claimed = the business owner claimed this record; this is not an endorsement or an independent check by Vizoryo. community_confirmed = a signed-in person confirmed the details look right; not necessarily the owner, and not an owner claim. owner_submitted = the details were typed in by someone who says they run the business; nobody has checked them and no audit ran. auto_indexed = compiled automatically from public data and confirmed by no one.","value":"auto_indexed"},{"@type":"PropertyValue","name":"fieldProvenance","description":"Per-field provenance: how many of the public sources read for this record carried each key business fact, and how strongly they agree. Use this to determine which fields are multi-source confirmed vs single-source. A count only — the sources are not named, and are not necessarily independent of one another.","value":"{\"name\":{\"source_count\":2,\"confidence\":1},\"phone\":{\"source_count\":2,\"confidence\":1},\"address\":{\"source_count\":1,\"confidence\":0.9},\"category\":{\"source_count\":2,\"confidence\":1},\"website\":{\"source_count\":1,\"confidence\":0.4}}"}]},{"@id":"https://www.vizoryo.com/en/business/pharmaceutical-company/galveston/chrysalis-biotherapeutics-inc#service-0","name":"TP508 Peptide Technology","@type":"Service","category":"product","provider":{"@id":"https://www.vizoryo.com/en/business/pharmaceutical-company/galveston/chrysalis-biotherapeutics-inc#business"},"areaServed":{"name":"Galveston","@type":"City"},"description":"An injectable drug designed to mitigate vascular damage, hemorrhage, and inflammation, and activate stem cells for tissue regeneration."},{"@id":"https://www.vizoryo.com/en/business/pharmaceutical-company/galveston/chrysalis-biotherapeutics-inc#service-1","name":"Treatments for Acute Respiratory Distress Syndrome (ARDS)","@type":"Service","category":"service","provider":{"@id":"https://www.vizoryo.com/en/business/pharmaceutical-company/galveston/chrysalis-biotherapeutics-inc#business"},"areaServed":{"name":"Galveston","@type":"City"},"description":"Development and commercialization of therapies for ARDS, including those caused by viral infections like COVID-19."},{"@id":"https://www.vizoryo.com/en/business/pharmaceutical-company/galveston/chrysalis-biotherapeutics-inc#service-2","name":"Solutions for Acute Radiation Exposure","@type":"Service","category":"service","provider":{"@id":"https://www.vizoryo.com/en/business/pharmaceutical-company/galveston/chrysalis-biotherapeutics-inc#business"},"areaServed":{"name":"Galveston","@type":"City"},"description":"Development of medical countermeasures to mitigate the effects of radiation exposure and increase survival rates."},{"@id":"https://www.vizoryo.com/en/business/pharmaceutical-company/galveston/chrysalis-biotherapeutics-inc#faq","name":"FAQ - Chrysalis Biotherapeutics, Inc.","@type":"FAQPage","mainEntity":[{"name":"What is Chrysalin (TP508)?","@type":"Question","acceptedAnswer":{"text":"Chrysalin (TP508) is a regenerative peptide in development for treating acute respiratory distress syndrome (ARDS) and as a nuclear countermeasure to mitigate radiation exposure effects.","@type":"Answer"}},{"name":"What is the focus of Chrysalis Biotherapeutics, Inc.?","@type":"Question","acceptedAnswer":{"text":"Chrysalis Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing treatments for serious respiratory disorders and acute radiation exposure.","@type":"Answer"}},{"name":"What is the status of the TP508 Nuclear Countermeasure Program?","@type":"Question","acceptedAnswer":{"text":"The TP508 Nuclear Countermeasure Program, funded by NIH and BARDA, is being developed under the FDA Animal Rule program with potential approval as early as 2027.","@type":"Answer"}}]}],"@context":"https://schema.org"},"created_at":"2026-06-12T09:46:29.307354+00:00","updated_at":"2026-06-28T03:15:39.656+00:00","faq":[{"answer":"Chrysalin (TP508) is a regenerative peptide in development for treating acute respiratory distress syndrome (ARDS) and as a nuclear countermeasure to mitigate radiation exposure effects.","category":"services","question":"What is Chrysalin (TP508)?"},{"answer":"Chrysalis Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing and commercializing treatments for serious respiratory disorders and acute radiation exposure.","category":"general","question":"What is the focus of Chrysalis Biotherapeutics, Inc.?"},{"answer":"The TP508 Nuclear Countermeasure Program, funded by NIH and BARDA, is being developed under the FDA Animal Rule program with potential approval as early as 2027.","category":"services","question":"What is the status of the TP508 Nuclear Countermeasure Program?"}],"country":"United States","og_image_url":"https://chrysbio.com/wp-content/uploads/2023/09/shutterstock_1505876450.jpg","industry_subtype":null,"profile_tier":"free","short_tagline":"Pharmaceutical Company in Galveston — Clinical stage biotechnology","primary_category":"Pharmaceutical Company","schema_type":"LocalBusiness","primary_address":{"city":"Galveston","region":"Texas","street":"2200 Market St, Galveston, TX 77550","country":"US","postal_code":"77550"},"geo_coordinates":{"lat":29.3059916,"lng":-94.793437},"service_areas":["Galveston"],"phone":"+14094974083","hours_by_day":null,"price_range":null,"review_summary":null,"certifications":[],"years_in_business":null,"founded_year":null,"specialties":["Clinical stage biotechnology"],"differentiators":[],"social_profiles":[{"url":"https://www.facebook.com/Chrysalis-Bio-Therapeutics-201562923330088/","platform":"facebook"},{"url":"https://twitter.com/chrysbioTX","platform":"twitter"}],"citations":[],"data_sources":["Website Scan","Schema.org Structured Data","Social Media Profiles","AI Content Analysis","Google Business Profile"],"languages_supported":["en"],"profile_language":"en","ai_readability_score":34,"claimed_at":null,"index_status":"listed","industry_category":"Pharmaceutical Company","llm_optimized_summary":"A pharmaceutical company in Galveston, United States, Chrysalis Biotherapeutics, Inc. focuses on clinical stage biotechnology. The company develops TP508 Peptide Technology and treatments for conditions such as Acute Respiratory Distress Syndrome (ARDS). It also provides solutions for acute radiation exposure, serving patients with serious respiratory disorders and individuals at risk of radiation exposure.","target_audience":["Patients with serious respiratory disorders","Individuals at risk of acute radiation exposure","Medical professionals and researchers"],"alternative_to":[],"data_trust_signal":"https://chrysbio.com","category_local":null,"city_local":null,"country_local":null,"is_regulated":false,"parent_profile_id":null,"profile_type":"standalone","branch_address":null,"branch_phone":null,"branch_hours":null,"branch_geo":null,"google_place_id":"ChIJccSGq2ueP4YRLg57Teg905Q","ai_mention_count":0,"last_ai_mention_at":null,"logo_url":"http://chrysbio.com/wp-content/uploads/2019/09/chrysbio_logo_whiteBG.jpg","url_path":"pharmaceutical-company/galveston/chrysalis-biotherapeutics-inc","business_name_en":"Chrysalis Biotherapeutics, Inc.","data_confidence":0.900181818181818,"ai_mention_score":null,"business_name_native":null,"canonical_domain":null,"social_proof":null,"external_links":{"maps_url":"https://www.google.com/maps/place/?cid=10723983205640900142","twitter_url":"https://twitter.com/chrysbioTX","facebook_url":"https://www.facebook.com/Chrysalis-Bio-Therapeutics-201562923330088/"},"amenities":[],"payment_methods":[],"operational_status":"open","is_software_product":false,"field_audit_trail":null,"amenities_typed":null,"industry_canonical":"Pharmaceutical Company","name_forms":["Chrysalis Biotherapeutics, Inc."],"same_as":["https://chrysbio.com","https://www.google.com/maps/place/?cid=10723983205640900142","https://www.facebook.com/Chrysalis-Bio-Therapeutics-201562923330088/","https://twitter.com/chrysbioTX"],"platform_signals":null,"record_checked_at":"2026-06-12T09:46:29.292+00:00","trust_state":"indexed","record_status":"auto_indexed","profile_completeness":{"filled":10,"total":15,"tier_unlocks":{"statistics":0,"intent_segments":0,"knowsabout_depth":0,"buyer_faq":0}},"freshness_days":116,"confirmation_count":0,"vizoryo_profile_id":"vizoryo:profile:06cb6e28-7aca-4df3-b124-3185c72a2a1f","canonical_summary":"A pharmaceutical company in Galveston, United States, Chrysalis Biotherapeutics, Inc. focuses on clinical stage biotechnology. The company develops TP508 Peptide Technology and treatments for conditions such as Acute Respiratory Distress Syndrome (ARDS). It also provides solutions for acute radiation exposure, serving patients with serious respiratory disorders and individuals at risk of radiation exposure.","citation":{"profile_url":"https://www.vizoryo.com/en/business/pharmaceutical-company/galveston/chrysalis-biotherapeutics-inc","record_status":"auto_indexed","index_status":"listed","vizoryo_profile_id":"vizoryo:profile:06cb6e28-7aca-4df3-b124-3185c72a2a1f","source_url":"https://chrysbio.com","name":"Chrysalis Biotherapeutics, Inc.","recommended_citation":"Chrysalis Biotherapeutics, Inc. — business identity (auto-indexed from public data; not confirmed by anyone) on Vizoryo. Source: https://www.vizoryo.com/en/business/pharmaceutical-company/galveston/chrysalis-biotherapeutics-inc"},"confidence_computed_at":"2026-06-28T03:15:39.764+00:00","ai_providers":[],"confidence_sources":["Schema.org Structured Data","AI Content Analysis","Google Business Profile","Website Scan"],"field_provenance":[{"field":"name","source_count":2,"confidence":1,"updated_at":"2026-06-28T03:15:39.764+00:00","confirmed_by":"cross_source"},{"field":"phone","source_count":2,"confidence":1,"updated_at":"2026-06-28T03:15:39.764+00:00","confirmed_by":"cross_source"},{"field":"address","source_count":1,"confidence":0.9,"updated_at":"2026-06-28T03:15:39.764+00:00","confirmed_by":"public_source"},{"field":"category","source_count":2,"confidence":1,"updated_at":"2026-06-28T03:15:39.764+00:00","confirmed_by":"cross_source"},{"field":"website","source_count":1,"confidence":0.4,"updated_at":"2026-06-28T03:15:39.764+00:00","confirmed_by":"public_source"}],"recommendations":[{"check_id":"review_quality","label":"Review Rating & Count","description":"Embed your Google star rating in your website code (using Schema.org AggregateRating) — a 4.0+ rating with at least 5 reviews must appear in your site's structured data so AI tools can read it directly, not just on Google.","tokens":{"businessName":"Chrysalis Biotherapeutics, Inc.","cmsHint":"","city":"Galveston"},"priority":"high"},{"check_id":"faq_presence","label":"Conversational FAQ (Q&A)","description":"Add a Frequently Asked Questions section to your site — AI assistants like Perplexity and ChatGPT actively look for question-and-answer content to quote directly in their responses.","tokens":{"businessName":"Chrysalis Biotherapeutics, Inc.","cmsHint":"","city":"Galveston"},"priority":"high"},{"check_id":"schema_sameas","label":"Entity Cross-References","description":"Add cross-reference links in your website's structured data pointing to your Google Business Profile, Wikipedia entry, or social media pages — AI tools cross-check these links to confirm you're a recognised, real-world business.","tokens":{"businessName":"Chrysalis Biotherapeutics, Inc.","cmsHint":"","city":"Galveston"},"priority":"high"}]}}